Who We Are

Using our proprietary drug discovery platform, we have created a pipeline of innovative infectious disease and cardiovascular product candidates.

PolyMedix is a clinical stage biotechnology company that is developing first-in-class, small-molecule drugs for the treatment of serious acute care conditions.

 

Press Releases

Featured Link

PolyMedix selected as Best Mid-Stage Product Development Company

 

---

Upcoming Event